Idexx Laboratories (IDXX) Shares Outstanding (Diluted Average) (2009 - 2026)

Idexx Laboratories' Shares Outstanding (Diluted Average) history runs 14 years deep, the most recent figure standing at $80.2 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) fell 2.15% year-over-year to $80.2 million; the TTM figure through Mar 2026 stood at $80.2 million (down 2.15% YoY), while the FY2025 annual figure was $81.0 million, down 2.67% from the prior year.
• Shares Outstanding (Diluted Average) was $80.2 million for Q1 2026 at Idexx Laboratories, down from $81.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $85.6 million in Q1 2022 to a low of $80.2 million in Q1 2026.
• Historically, Shares Outstanding (Diluted Average) has averaged $83.3 million across 5 years, with a median of $84.0 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Diluted Average) retreated 0.0% in 2024, then fell 3.21% in 2025.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $84.6 million in 2022, then slipped by 0.74% to $84.0 million in 2023, then fell by 0.87% to $83.2 million in 2024, then decreased by 2.67% to $81.0 million in 2025, then slipped by 1.07% to $80.2 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $80.2 million (Q1 2026), $81.0 million (Q4 2025), and $81.2 million (Q3 2025), per Business Quant data.